Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert Y Lin

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
American Journal of Hematology|February 1, 2012
Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammationChia Chi Sun, Valentina Vaja, Jodie L Babitt, et al.
Diabetes|January 30, 2007
Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptorLeileata M Russo, Elisabetta del Re, Dennis Brown, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 5, 2014
Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1βYueshui Zhao, Xiaoqiu Xiao, Stuart J Frank, et al.
Blood|March 11, 2008
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogeninYin Xia, Jodie L Babitt, Yisrael Sidis, et al.
The Journal of Biological Chemistry|October 12, 2004
Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free systemElisabetta del Re, Yisrael Sidis, David A Fabrizio, et al.
The Journal of Biological Chemistry|March 5, 2004
In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2Elisabetta del Re, Jodie L Babitt, Alnoor Pirani, et al.
American Journal of Nephrology|September 26, 2012
Statement of concern about a commercial assay used to measure soluble hemojuvelin in humansOrlando M Gutiérrez, Chia Chi Sun, Wenjie Chen, et al.
Kidney International|April 27, 2012
Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesisGal Finer, H William Schnaper, Yashpal S Kanwar, et al.
Haematologica|August 10, 2012
A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serumWenjie Chen, Chia Chi Sun, Shanzhuo Chen, et al.
American Journal of Physiology. Cell Physiology|January 29, 2005
Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathwayRichard Bouley, Herbert Y Lin, Malay K Raychowdhury, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
American Journal of Hematology|February 1, 2012
Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammationChia Chi Sun, Valentina Vaja, Jodie L Babitt, et al.
Diabetes|January 30, 2007
Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptorLeileata M Russo, Elisabetta del Re, Dennis Brown, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 5, 2014
Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1βYueshui Zhao, Xiaoqiu Xiao, Stuart J Frank, et al.
Blood|March 11, 2008
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogeninYin Xia, Jodie L Babitt, Yisrael Sidis, et al.
The Journal of Biological Chemistry|October 12, 2004
Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free systemElisabetta del Re, Yisrael Sidis, David A Fabrizio, et al.
The Journal of Biological Chemistry|March 5, 2004
In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2Elisabetta del Re, Jodie L Babitt, Alnoor Pirani, et al.
American Journal of Nephrology|September 26, 2012
Statement of concern about a commercial assay used to measure soluble hemojuvelin in humansOrlando M Gutiérrez, Chia Chi Sun, Wenjie Chen, et al.
Kidney International|April 27, 2012
Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesisGal Finer, H William Schnaper, Yashpal S Kanwar, et al.
Haematologica|August 10, 2012
A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serumWenjie Chen, Chia Chi Sun, Shanzhuo Chen, et al.
American Journal of Physiology. Cell Physiology|January 29, 2005
Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathwayRichard Bouley, Herbert Y Lin, Malay K Raychowdhury, et al.
Pageof 8